Biotop-report 2013

71

BioTOPics 46 | September 2013 

BioTOP-Report

 

Biotech Companies

moloX GmbH

moloX GmbH is a company focusing on custom protein production in bacterial and in-

sect cell expression systems and subsequent protein purification to ultra-high purity. On 

customer demand a team of experts can perform protein crystallization experiments and 

determine the 3D structure of target proteins by X-ray crystallography.

molox.de

MRI.TOOLS GmbH

MRI.TOOLS´s main focus is the development, sales and services of innovative hardware 

and novel technology for magnetic resonance imaging (MRI), computed tomography (CT) 

and positron emission tomography (PET). Our product portfolio encompasses enabling 

radiofrequency (RF) coils tailored for a broad range of applications, devices designed for 

reliable cardiac gating of imaging plus accessories that will make your daily life more com-

fortable. MRI.TOOLS is also very proud to offer consulting services such as validation and 

certification of medical devices.

mritools.de

Nano Access Technologies Ltd.

The company addresses the combined access to key technologies such as life science and 

nanotechnology. As a first product, a low cost AFM for operation with so-called active can-

tilevers has been developed. Besides this, functionalized cantilevers for future biosensors 

are another focus of the company.

nano-access.com

Nanolytics Gesellschaft für 

Kolloidanalytik mbH

We are a contract laboratory specializing in the physico-chemical characterization of phar-

maceutical proteins, biopolymers, nanoparticles and colloidal systems. Our core-compe-

tences are Analytical Ultracentrifugation, in combination with Static and Dynamic Light 

Scattering as well as spectroscopic (CD, fluorescence) and thermodynamic techniques (ITC, 

DSC).

nanolytics.de

Nanopartica GmbH

Nanopartica GmbH optimizes existing products of other companies, but are also devel-

oping new products and materials. In particular, companies in surface-, bio-, and medi-

cal-technology can benefit from nanopartica. By means of functionalized polymers, we can 

encapsulate guest molecules (drugs, dyes, vitamins), particles (gold, silver, platinum), or 

ions. This will indirectly change the guests properties and expands its scope.

nanopartica.com

nanoPET Pharma GmbH

As a technology and service provider to the biopharmaceutical industry nanoPET focuses 

on the R&D, production as well as marketing of innovative drug substances for diagnostic 

imaging based on novel nanoparticular materials. nanoPET offers consulting and contract 

research services, preclinical contrast agents (MRT, CT, US, NIR, PET) as catalog items and 

pursues the preclinical development of its patented core technology of inorganic nanopar-

ticle PET tracers.

nanopet-pharma.com

New Medical Enzymes AG

Medical Enzymes AG is a privately held innovative biopharmaceutical company with a fo-

cus on therapeutically useful enzymes. The company has developed a new product family 

based on amino acid depleting enzymes. This unique approach is highly effective against 

cancer - the major target market of Medical Enzymes AG.

medical-enzymes.com

NovaBiotec

®

 Dr. Fechter GmbH

Microbiological and chemical investigations, in particular of soil, water and air samples, 

planning / inspection of sanitation, in particular analytics and sanitation support for mould 

and dry rot, incl. education in this field. Delivery of production auxilliaries and support for 

biogas plants with biological treatment processes incl. application, insulation and preser-

vation of enzymes. Research, development and marketing of test kits for breweries and 

malthouses.

novabiotec.de

Novamol GmbH

Development and manufacture of human and veterinary food supplements and health-en-

hancing products.

novamol.com

NOXXON Pharma AG

NOXXON Pharma is a biopharmaceutical company pioneering the development of a new 

class of proprietary therapeutics called Spiegelmers. Spiegelmers are the chemically syn-

thesized, non-immunogenic alternative to antibodies. NOXXON has a diversified portfolio 

of clinical stage Spiegelmer therapeutics: Spiegelmer

®

 NOX-E36, Spiegelmer

®

 NOX-A12, 

Spiegelmer

®

 NOX-H94. The Spiegelmer platform provides the Company with powerful and 

unique discovery capabilities, which have generated a number of additional leads under 

preclinical investigation. Located in Berlin, Germany, NOXXON is a well financed mature 

biotech company with a strong syndicate of international investors, approx. 60 employees 

and a highly experienced management team.

noxxon.com

NutriNeu GmbH

NutriNeu GmbH develops a new generation of pre and probiotics. First products are based 

on microorganisms that were isolated with our proprietary GlycoScreen technology (an-

tibody directed isolation of microorganisms expressing specific carbohydrate structures). 

Besides developing own products, NutriNeu GmbH offers services in the fields of micro-

biology, process development and Glycoanalytic. NutriNeu GmbH also helps customers to 

investigate the probiotic properties of their microorganisms.

OakLabs GmbH

OakLabs provides the most flexible products and services for large scale custom SNP ge-

notyping on the market. OakLabs offers several formats for analysing a variable number of 

SNPs in any sequenced organism. 

oak-labs.com

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH is a clinical development company focusing on diagnostic 

radiopharmaceuticals. 

octreopharmsciences.com

---